National Institute of Health (NIH) in the United States has released its strategic fiscal plan for 2016-2020 which has placed a heavy focus on funding research and development in the field of rare diseases. This strategic plan was prepared at the request of the United States Congress, wherein NIH will use this framework to turn scientific discoveries into better health.
Since one of the priorities of this Strategic Plan is to advance opportunities presented by rare diseases, they aim to support and help patients with the NIH Clinical Center’s Undiagnosed Diseases Program. NIH will also promote the recently established Undiagnosed Diseases Network to promote use of genomic data in disease diagnosis and enlist the help of basic researchers in elucidating disease mechanisms in order that treatments can be developed. NIH also plans to advance the goals of Precision Medicine.
According to NIH, it is uniquely positioned to advance developments as well as capitalize on the opportunities, presented by rare diseases over the next 5 years. Finally, NIH predicts that the research supported by them will directly contribute to FDA-approved therapies for at least a dozen rare diseases.